Table 3.
Contraception plan stratified by delivery timing
| Contraception method | Pre–COVID-19 pandemic | During the COVID-19 pandemic | P value |
|---|---|---|---|
| n=1133 | n= 981 | ||
| Contraception plan | .004 | ||
| None | 144 (12.7) | 147 (15.0) | .13 |
| Condoms | 380 (33.5) | 333 (33.9) | .84 |
| Depo-Provera | 25 (2.2) | 13 (1.3) | .13 |
| LARC | 222 (19.6) | 132 (13.5) | <.001 |
| COC or POP or patch or NuvaRing | 297 (26.2) | 293 (30.0) | .06 |
| PPTL | 34 (3.0) | 32 (3.3) | .73 |
| Other | 31 (2.7) | 31 (3.2) | .57 |
Data are presented as number (percentage).
COC, combined oral contraceptive; LARC, long-acting reversible contraceptive; POP, progesterone only pill; PPTL, postpartum tubal ligation.
Sakowicz. COVID-19 pandemic and postpartum care provision. Am J Obstet Gynecol MFM 2021.